Whereas the incidence of CLL is also sex-dependent, the origin of CLL cell remains still unknown and the disease remains still incurable, these findings should initiate a development of new approaches targeting RelB and alternative NF-κB pathway that might be discriminative between CLL leukemogenesis in males and females. This evidence concerns the gene RELB and B-cell chronic lymphocytic leukemia.